Table 3 The relarionship between mGPS score and clinicopathological characteristics
variable | mGPS 0 | mGPS 1 | mGPS 2 | P Value | ||||
|---|---|---|---|---|---|---|---|---|
(N = 493) | (N = 49) | (N = 49) | ||||||
Age | (years) | 0.101 | ||||||
< 75 | 345 | 58.1% | 35 | 5.9% | 29 | 4.9% | ||
≥75 | 148 | 24.9% | 14 | 2.4% | 23 | 3.9% | ||
Sex | 0.283 | |||||||
female | 198 | 33.3% | 14 | 2.4% | 20 | 3.4% | ||
male | 295 | 49.7% | 35 | 5.9% | 32 | 5.4% | ||
BMI | 0.302 | |||||||
≥18.5 | 404 | 87.8% | 44 | 7.8% | 42 | 7.5% | ||
< 18.5 | 56 | 10.0% | 5 | 0.9% | 10 | 1.8% | ||
tumor location | 0.153 | |||||||
right side | 159 | 26.8% | 60 | 10.1% | 37 | 6.2% | ||
left | 250 | 42.1% | 57 | 9.6% | 31 | 5.2% | ||
opearation approach | 0.001 | |||||||
open | 287 | 48.4% | 40 | 6.7% | 38 | 6.4% | ||
lap | 205 | 34.6% | 9 | 1.5% | 14 | 2.4% | ||
Tumor size | (cm) | < 0.001 | ||||||
< 5 | 317 | 55.0% | 19 | 3.3% | 11 | 1.9% | ||
≥5 | 163 | 28.3% | 26 | 4.5% | 40 | 6.9% | ||
T | 0.014 | |||||||
T2/3 | 412 | 69.4% | 41 | 6.9% | 35 | 5.9% | ||
T4 | 81 | 13.6% | 8 | 1.3% | 17 | 2.9% | ||
N | 0.17 | |||||||
N0 | 247 | 41.7% | 27 | 4.6% | 33 | 5.6% | ||
N1/2/3 | 245 | 41.3% | 22 | 3.7% | 19 | 3.2% | ||
CEA | (ng/ml) | 0.629 | ||||||
< 5 | 312 | 58.1% | 30 | 5.6% | 29 | 5.4% | ||
≥5 | 137 | 25.5% | 12 | 2.2% | 17 | 3.2% | ||
CA19–9 | (U/ml) | 0.274 | ||||||
< 37 | 365 | 68.4% | 34 | 6.4% | 29 | 5.4% | ||
≥37 | 87 | 16.3% | 7 | 1.3% | 12 | 2.2% | ||